We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
-2.39%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$174M
AUM Growth
-$2.27M
(-1.3%)
Cap. Flow
+$10.4M
Cap. Flow
% of AUM
6.01%
Top 10 Holdings %
Top 10 Hldgs %
63.46%
Holding
237
New
6
Increased
44
Reduced
166
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cibus
CBUS
|
+$22.7M |
| 2 |
Babcock & Wilcox
BW
|
+$14.2M |
| 3 |
CMA
Comerica
CMA
|
+$237K |
| 4 |
Palo Alto Networks
PANW
|
+$207K |
| 5 |
Zions Bancorporation
ZION
|
+$206K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$12.6M |
| 2 |
Syntax Stratified LargeCap ETF
SSPY
|
+$2.72M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$1.59M |
| 4 |
ADC Therapeutics
ADCT
|
+$676K |
| 5 |
SMDY
Syntax Stratified MidCap ETF
SMDY
|
+$341K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.28% |
| 2 | Industrials | 9.63% |
| 3 | Technology | 6.93% |
| 4 | Consumer Staples | 6.52% |
| 5 | Consumer Discretionary | 5.88% |
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q2 2023 Portfolio in Review
As of Q2 2023, Vantage Consulting Group held 237 positions worth $174M, down 1.3% from $176M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Vantage Consulting Group deployed $10.4M of net new capital in Q2 2023, opening 6 new positions and adding to 44 existing holdings. Its largest new stake was Cibus: 1,262,842 shares worth $13.3M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Royalty Pharma, an estimated $12.6M trimmed.
- Vantage Consulting Group's largest Q2 2023 buy was Cibus: 1,262,842 shares worth $13.3M.
- Vantage Consulting Group added most to Comerica in Q2 2023, an estimated $237K increase.
- Vantage Consulting Group's biggest Q2 2023 reduction was Royalty Pharma, cutting an estimated $12.6M.
- Vantage Consulting Group fully exited General Mills in Q2 2023, selling an estimated $237K.
- Vantage Consulting Group's ten largest holdings make up 63% of its $174M portfolio in Q2 2023.
- Vantage Consulting Group opened 6 new positions and closed 21 in Q2 2023.
- Vantage Consulting Group's portfolio value fell 1.3% quarter-over-quarter to $174M.
Based on Vantage Consulting Group's 13F filing for Q2 2023, filed 11 Aug 2023.